Rosenberg Matthew Hamilton Increases Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Rosenberg Matthew Hamilton increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 117.4% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 711 shares of the company’s stock after buying an additional 384 shares during the period. Rosenberg Matthew Hamilton’s holdings in GE HealthCare Technologies were worth $56,000 as of its most recent filing with the SEC.

Other large investors have also added to or reduced their stakes in the company. LGT Financial Advisors LLC boosted its stake in GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after acquiring an additional 251 shares during the last quarter. Fred Alger Management LLC bought a new stake in shares of GE HealthCare Technologies in the 2nd quarter worth approximately $26,000. Capital Performance Advisors LLP purchased a new position in GE HealthCare Technologies in the third quarter valued at approximately $26,000. Ashton Thomas Securities LLC purchased a new position in GE HealthCare Technologies in the third quarter valued at approximately $26,000. Finally, Elkhorn Partners Limited Partnership bought a new position in GE HealthCare Technologies during the second quarter valued at $31,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analysts Set New Price Targets

Several analysts have issued reports on GEHC shares. UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lowered their target price for the company from $84.00 to $74.00 in a research note on Thursday, September 26th. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Evercore ISI increased their target price on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research note on Wednesday, September 18th. Finally, Stifel Nicolaus upped their price target on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $96.00.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock opened at $84.13 on Wednesday. GE HealthCare Technologies Inc. has a 1-year low of $71.31 and a 1-year high of $94.55. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The firm has a market capitalization of $38.44 billion, a PE ratio of 23.11, a price-to-earnings-growth ratio of 2.90 and a beta of 1.11. The firm’s 50 day simple moving average is $82.13 and its 200 day simple moving average is $84.27.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The firm had revenue of $4.86 billion for the quarter, compared to analysts’ expectations of $4.87 billion. During the same quarter in the prior year, the firm posted $0.99 earnings per share. The business’s quarterly revenue was up .9% on a year-over-year basis. As a group, analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Tuesday, January 14th. This represents a $0.14 annualized dividend and a dividend yield of 0.17%. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.85%.

Insider Activity

In other news, CEO Roland Rott sold 3,577 shares of the firm’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the sale, the chief executive officer now owns 24,298 shares in the company, valued at approximately $2,101,291.04. This trade represents a 12.83 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.